Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: J Cell Biochem. 2021 May 14;123(1):4–21. doi: 10.1002/jcb.29952

Figure 5. BAG3 in neurodegenerative disorders.

Figure 5.

Diagrams illustrate the molecular mechanism of BAG3 in regulating neurodegenerative disorders including Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD) and Parkinson’s disease (PD).